Meeting
2023 ASCO Genitourinary Cancers Symposium
High-dose chemotherapy with autologous stem cell transplant (HDCT) for patients (pts) with advanced germ-cell tumors (aGCT): Real-world evidence from a tertiary cancer center in Brazil.
Authors
Gabriel Berlingieri Polho
Instituto do Câncer do Estado de São Paulo, University of São Paulo, Sao Paulo, Brazil
Gabriel Berlingieri Polho , Mateus Trinconi Cunha , Erick Menezes Xavier , Jamile Almeida Silva , Cassio Murilo Trovo Hidalgo Filho , Nathália de Souza Del Rey Crusoé , Marcelo Junqueira Atanazio , Vivian Horita , Guilherme Fialho de Freitas , David Queiroz Borges Muniz , Vanderson Geraldo Rocha , Jose Mauricio Mota
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session C: Renal Cell Cancer; Adrenal, Penile, Urethral and Testicular Cancers
Track
Renal Cell Cancer,Adrenal Cancer,Penile Cancer,Testicular Cancer,Urethral Cancer
Sub Track
Quality of Care/Quality Improvement and Real-World Evidence
Citation
J Clin Oncol 41, 2023 (suppl 6; abstr 414)
DOI
10.1200/JCO.2023.41.6_suppl.414
Abstract #
414
Poster Bd #
L16
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Genitourinary Cancers Symposium
Real-world treatment outcomes in patients with advanced renal cell carcinoma who receive axitinib plus pembrolizumab in the first-line setting in Canadian cancer centers.
First Author: Carissa Beaulieu
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Exploring real-world outcomes with nivolumab plus chemotherapy in patients with advanced gastroesophageal adenocarcinoma.
First Author: Clara Chen
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Use of circulating tumor DNA (ctDNA) for early assessment of treatment response in patients with advanced colorectal cancer (aCRC): A real-world (RW) analysis.
First Author: Pashtoon Murtaza Kasi
Poster
2022 ASCO Annual Meeting
Real-world outcomes of Black women versus non-Hispanic White women with advanced triple-negative breast cancer treated with immune checkpoint inhibitors at an urban cancer center.
First Author: Jeffrey Aldrich